WallStSmart

America Movil SAB de CV ADR (AMX)vsMedtronic PLC (MDT)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

America Movil SAB de CV ADR generates 2559% more annual revenue ($943.64B vs $35.48B). MDT leads profitability with a 13.0% profit margin vs 8.8%. AMX appears more attractively valued with a PEG of 1.17. AMX earns a higher WallStSmart Score of 69/100 (B-).

AMX

Strong Buy

69

out of 100

Grade: B-

Growth: 4.0Profit: 7.0Value: 10.0Quality: 4.0
Piotroski: 6/9Altman Z: 1.37

MDT

Buy

56

out of 100

Grade: C

Growth: 4.0Profit: 6.5Value: 7.3Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

AMXUndervalued (+67.3%)

Margin of Safety

+67.3%

Fair Value

$72.07

Current Price

$24.76

$47.31 discount

UndervaluedFair: $72.07Overvalued
MDTSignificantly Overvalued (-255.7%)

Margin of Safety

-255.7%

Fair Value

$24.34

Current Price

$87.89

$63.55 premium

UndervaluedFair: $24.34Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

AMX5 strengths · Avg: 8.8/10
Free Cash FlowQuality
$42.68B10/10

Generating 42.7B in free cash flow

Market CapQuality
$70.61B9/10

Large-cap with strong market position

Return on EquityProfitability
20.5%9/10

Every $100 of equity generates 21 in profit

P/E RatioValuation
15.2x8/10

Attractively priced relative to earnings

Operating MarginProfitability
20.1%8/10

Strong operational efficiency at 20.1%

MDT4 strengths · Avg: 8.3/10
Market CapQuality
$110.62B9/10

Large-cap with strong market position

Price/BookValuation
2.3x8/10

Reasonable price relative to book value

Operating MarginProfitability
20.0%8/10

Strong operational efficiency at 20.0%

Free Cash FlowQuality
$2.30B8/10

Generating 2.3B in free cash flow

Areas to Watch

AMX4 concerns · Avg: 3.0/10
Revenue GrowthGrowth
3.4%4/10

3.4% revenue growth

EPS GrowthGrowth
4.0%4/10

4.0% earnings growth

Price/BookValuation
72.8x2/10

Trading at 72.8x book value

Altman Z-ScoreHealth
1.372/10

Distress zone — elevated risk

MDT1 concerns · Avg: 2.0/10
EPS GrowthGrowth
-11.8%2/10

Earnings declined 11.8%

Comparative Analysis Report

WallStSmart Research

Bull Case : AMX

The strongest argument for AMX centers on Free Cash Flow, Market Cap, Return on Equity. PEG of 1.17 suggests the stock is reasonably priced for its growth.

Bull Case : MDT

The strongest argument for MDT centers on Market Cap, Price/Book, Operating Margin.

Bear Case : AMX

The primary concerns for AMX are Revenue Growth, EPS Growth, Price/Book. Debt-to-equity of 2.53 is elevated, increasing financial risk.

Bear Case : MDT

The primary concerns for MDT are EPS Growth.

Key Dynamics to Monitor

MDT carries more volatility with a beta of 0.73 — expect wider price swings.

MDT is growing revenue faster at 8.7% — sustainability is the question.

AMX generates stronger free cash flow (42.7B), providing more financial flexibility.

Monitor TELECOM SERVICES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

AMX scores higher overall (69/100 vs 56/100). Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

America Movil SAB de CV ADR

COMMUNICATION SERVICES · TELECOM SERVICES · USA

Amrica Mvil, SAB de CV provides telecommunications services in Latin America and internationally. The company is headquartered in Mexico City, Mexico.

Visit Website →

Medtronic PLC

HEALTHCARE · MEDICAL DEVICES · USA

Medtronic plc is an American-Irish registered medical device company that primarily operates in the United States. Medtronic has an operational and executive headquarters in Fridley, Minnesota in the US.

Want to dig deeper into these stocks?